Antibody Persistence And Long Term Safety Of A Chikungunya Virus Vaccine (VLA1553)
Clinical trial NCT04838444 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04838444
- Sponsor
- Valneva Austria GmbH
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-02
- Primary completion
- 2023-03-03
- Enrollment
- 363
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.